-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Jin Hongjun, Director of the Hebei Provincial Administration for Market Regulation, visited Guangxiang Pharmaceutical for a research visit.
Category:
Time：2020-05-29
On the afternoon of May 27, Jin Hongjun, Director of the Hebei Provincial Administration for Market Regulation, visited Hebei Guangxiang Pharmaceutical Co., Ltd. of Shisi Pharmaceutical Group in the Bohai New Area to conduct a research visit on work related to production safety.
On the afternoon of May 27, Jin Hongjun, Director of the Hebei Provincial Administration for Market Regulation, visited Hebei Guangxiang Pharmaceutical Co., Ltd. of Shisi Pharmaceutical Group in the Bohai New Area to conduct a research visit on work safety production.
Jin Hongjun obtained detailed information from Han Shuqin, Chairwoman of Guangxiang Pharmaceutical, regarding the company’s current production, operations, and safety conditions.
Jin Hongjun said that the company’s approach—actively implementing safety production measures, strengthening awareness of safety red lines, and driving improvements in safety management levels—is worthy of recognition. We must continue to attach great importance to safety production work, ensure accountability is fully implemented, intensify safety education and training for every employee and operator, reinforce emergency drills, and at the same time, pay close attention to equipment management and resolutely prevent any safety incidents from occurring.
Relevant officials from Cangzhou City and the Cangzhou Bohai New Area attended the research visit.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license